Streetbeat News

Stock Prices

RCKT

Rocket Pharmaceuticals has completed patient enrollment for its global Phase 2 clinical trial of RP-A501, aimed at treating Danon Disease in male patients. This marks a significant milestone in the development of this potential treatment.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 11:06 am

AAPL

INTC

MSFT

QQQ

SPY

VSAT

U.S. stocks are set for a positive start as traders anticipate the August retail sales report and a potential Fed rate cut. Tech stocks, including Intel and Microsoft, are gaining attention. Analysts expect a 25 basis-point rate cut, with labor and growth data being crucial for future market movements.

Portfolio Pulse from Shanthi Rexaline

September 17, 2024 | 11:02 am

ACDC

MERC

WY

Insider purchases were made in ProFrac Holding, Weyerhaeuser, and Mercer International, indicating potential confidence in these companies. ProFrac and Weyerhaeuser reported downbeat sales, while Mercer International posted upbeat sales.

Portfolio Pulse from Avi Kapoor

September 17, 2024 | 10:47 am

AAPL

AVGO

MU

NVDA

U.S. markets closed mixed with the S&P 500 slightly up and the Nasdaq down due to tech stock declines. Apple fell on weak iPhone 16 demand, affecting chipmakers like Nvidia, Broadcom, and Micron. The NY Empire State Manufacturing Index rose significantly. Most S&P 500 sectors gained, except for IT and consumer discretionary. Asian markets were mixed, with Japan's Nikkei down and Hong Kong's Hang Seng up. European markets advanced, and crude oil prices steadied amid U.S. production concerns. Gold held above $2,600.

Portfolio Pulse from Akanksha Bakshi

September 17, 2024 | 10:47 am

FERG

Ferguson reported Q4 2024 earnings per share of $2.98, surpassing the analyst estimate of $2.82. However, its sales of $7.946 billion fell short of the expected $7.993 billion, despite a 1.38% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 10:46 am

KLTO

ANEW MEDICAL has changed its name to Klotho Neurosciences, Inc. and its ticker symbol to 'KLTO'. This change does not affect current shareholders, and no action is required from them.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 10:34 am

RFAI

RF Acquisition has announced an updated per share redemption price in relation to its upcoming special meeting. This update is crucial for investors as it may impact their decisions regarding share redemptions.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 10:22 am

NVDA

ORCL

TSLA

Elon Musk and Larry Ellison requested more Nvidia GPUs from CEO Jensen Huang during a dinner, highlighting the high demand for Nvidia's AI chips. Oracle and Tesla both rely on Nvidia's technology for AI applications, amid a global chip shortage.

Portfolio Pulse from Benzinga Neuro

September 17, 2024 | 10:06 am

MRK

Daiichi Sankyo and Merck's phase 3 trial of patritumab deruxtecan shows significant improvement in progression-free survival for EGFR-mutated NSCLC patients. The trial met its primary endpoint, with overall survival data still being assessed.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 10:03 am

GLMD

INTC

SMSI

Intel shares rose 6.9% in pre-market trading due to a strategic collaboration with AWS to advance US-based chip manufacturing. Several other stocks, including Galmed Pharmaceuticals and Smith Micro Software, also saw significant pre-market movements.

Portfolio Pulse from Avi Kapoor

September 17, 2024 | 9:48 am